Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Jordi Remón, Benjamin Besse, Santiago Ponce-Aix, Ana Callejo, K. Al-Rabi, Reyes Bernabé and 16 more
- Rank
- 43 of 3,639
- Percentile
- top 1.2%
- Where
- Annals of Oncology, 2023
- Citations
- 79
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.